A. Shoaibi

发表

Genome Sequence of Theileria parva, a Bovine Pathogen That Transforms Lymphocytes

Jonathan E. Allen, Samuel V. Angiuoli, Bernard B. Suh, 2005, Science.

Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

Jonathan E. Allen, Samuel V. Angiuoli, Bernard B. Suh, 2002, Nature.

A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data

Jennifer C. Nelson, Andrea J. Cook, Onchee Yu, 2016, EGEMS.

When should case‐only designs be used for safety monitoring of medical products?

David Madigan, Malcolm Maclure, Bruce Fireman, 2012, Pharmacoepidemiology and drug safety.

MINI-SENTINEL METHODS FRAMEWORK FOR ASSESSMENT OF SIGNAL REFINEMENT POSITIVE RESULTS

R. Ouellet-Hellstrom, M. Raebel, J. Glanz, 2013 .

MINI-SENTINEL MEDICAL PRODUCT ASSESSMENT SIGNAL REFINEMENT OF ANGIOEDEMA EVENTS IN ASSOCIATION WITH USE OF DRUGS THAT ACT ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM REPORT

M. Reichman, Adrian F. Hernandez, S. Hennessy, 2017 .

The Summary Report of the Second National Institute of Allergy and Infectious Disease / Food Allergy and Anaphylaxis

A. Fine, S. Andrade, W. Cooper, 2013 .

Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database

G. Dores, P. Saunders-Hastings, A. Shoaibi, 2021, PloS one.

Diagnosis‐based cohort augmentation using laboratory results data: The case of chronic kidney disease

Christine Y. Lu, J. Gagne, M. Raebel, 2018, Pharmacoepidemiology and drug safety.

Gender Differencesin the Treatment of Non-ST-Segment Elevation Myocardial Infarction

J. Chen, M. Roe, D. Tavris, 2010 .

Gender Differences in the Treatment of Non–ST‐Segment Elevation Myocardial Infarction

M. Roe, D. Tavris, A. Shoaibi, 2010, Clinical cardiology.

Gender differences in correlates of troponin assay in diagnosis of myocardial infarction.

S. McNulty, D. Tavris, A. Shoaibi, 2009, Translational research : the journal of laboratory and clinical medicine.

Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.

Adrian F Hernandez, Sengwee Toh, Mark Levenson, 2012, Archives of internal medicine.

Characterization of test positivity among patients with coronavirus disease 2019 (COVID-19) in three electronic health records databases, February–November 2020

P. Saunders-Hastings, Tainya C. Clarke, A. Shoaibi, 2022, BMC Public Health.

Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19

S. Anderson, E. Priest, Tainya C. Clarke, 2022, PloS one.

A critical review of methods to evaluate the impact of FDA regulatory actions

J. Gurwitz, S. Andrade, B. Briesacher, 2013, Pharmacoepidemiology and drug safety.

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases

Yuehua Wu, C. Reich, J. Hornberger, 2022, The Lancet.

Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020

S. Black, R. Forshee, T. MaCurdy, 2022, Vaccine.

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years

R. Forshee, T. MaCurdy, A. Shoaibi, 2022, Vaccine.

Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk.

Jason Roy, Marsha A Raebel, Kevin Haynes, 2017, Journal of comparative effectiveness research.

Serial analysis of gene expression in Plasmodium falciparum reveals the global expression profile of erythrocytic stages and the presence of anti-sense transcripts in the malarial parasite.

L. M. Cummings, D. Wirth, S. Patankar, 2001, Molecular biology of the cell.

Serial analysis of gene expression (SAGE) in Plasmodium falciparum: application of the technique to A-T rich genomes.

L. M. Cummings, D. Wirth, D. Kyle, 2001, Molecular and biochemical parasitology.

Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14

Jonathan E. Allen, Samuel V. Angiuoli, Bernard B. Suh, 2002, Nature.

Radiation Sensitivity of Human Carcinoma Cells Transfected with Small Interfering RNA Targeted against Cyclooxygenase-2

C. N. Coleman, S. T. Palayoor, A. Shoaibi, 2005, Clinical Cancer Research.

Effect of Radiation and Ibuprofen on Normoxic Renal Carcinoma Cells Overexpressing Hypoxia-Inducible Factors by Loss of von Hippel–Lindau Tumor Suppressor Gene Function

C. N. Coleman, P. Tofilon, S. T. Palayoor, 2004, Clinical Cancer Research.

Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System

J. Gagne, M. Reichman, J. Nelson, 2018, Pharmacoepidemiology and drug safety.

Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older

R. Forshee, T. MaCurdy, J. Kelman, 2022, Vaccine.

Characterization of COVID-19 Hospitalized Patients in Three United States Electronic Health Record Databases

A. Hettinger, P. Saunders-Hastings, Tainya C. Clarke, 2023, Pathogens.

Immune globulin usage trends in commercially insured and Medicare populations, 2009–2019

D. Scott, T. MaCurdy, G. Dores, 2023, Transfusion.

Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database

A. Shoaibi, L. Eckert, H. Wong, 2021, Drug Safety.

Applying sequential surveillance methods that use regression adjustment or weighting to control confounding in a multisite, rare-event, distributed setting: Part 2 in-depth example of a reanalysis of the measles-mumps-rubella-varicella combination vaccine and seizure risk.

Andrea J Cook, Lisa Jackson, Michael Nguyen, 2019, Journal of clinical epidemiology.

Mini‐Sentinel methods: framework for assessment of positive results from signal refinement

Azadeh Shoaibi, M. Raebel, J. Glanz, 2014, Pharmacoepidemiology and drug safety.

Methods for using clinical laboratory test results as baseline confounders in multi‐site observational database studies when missing data are expected

James Flory, Jason Roy, Kevin Haynes, 2016, Pharmacoepidemiology and drug safety.

The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS)-an assessment of the literature.

Azadeh Shoaibi, D. Tavris, A. Shoaibi, 2004, Diabetes technology & therapeutics.

Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini‐Sentinel Distributed Database

Sengwee Toh, Kevin Haynes, Sean Hennessy, 2013, Pharmacoepidemiology and drug safety.

Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016-2018.

T. MaCurdy, A. Shoaibi, J. Simard, 2021, Vaccine.

Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: A Self-Controlled Study in the U.S.

R. Forshee, J. Kelman, Tainya C. Clarke, 2023, medRxiv.

Validation of anaphylaxis in the Food and Drug Administration's Mini‐Sentinel

Azadeh Shoaibi, Sarah Foy, A. Fine, 2013, Pharmacoepidemiology and drug safety.

Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years.

R. Forshee, A. Shoaibi, D. Beachler, 2023, JAMA pediatrics.

Bleeding Events Following Concurrent Use of Warfarin and Oseltamivir by Medicare Beneficiaries

J. Racoosin, T. MaCurdy, C. Worrall, 2013, The Annals of pharmacotherapy.

Multivariable confounding adjustment in distributed data networks without sharing of patient‐level data

Sengwee Toh, Mark Levenson, Sean Hennessy, 2013, Pharmacoepidemiology and drug safety.

Comparative Risk for Angioedema Associated with the Use of Drugs That Target the Renin-angiotensin-aldosterone System

Mark S Levenson, M. Reichman, Adrian F. Hernandez, 2010 .

A critical review of methods to evaluate the impact of FDA regulatory actions

Joann L. Wagner, J. Gurwitz, S. Andrade, 2013, Pharmacoepidemiology and drug safety.

Safety of Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID-19 Vaccines in US Children Aged 6 months to 17 years

R. Forshee, A. Shoaibi, D. Beachler, 2023, medRxiv.

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years

R. Forshee, A. Shoaibi, K. Amend, 2024, JAMA network open.

Risk of Adverse Events Following Monovalent Third or Booster Dose of COVID-19 mRNA Vaccination in U.S. Adults Ages 18 Years and Older

R. Forshee, A. Shoaibi, N. Selvam, 2024, medRxiv.

Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.

R. Forshee, J. Kelman, Tainya C. Clarke, 2023, Vaccine.